Production (Stage)
Semler Scientific, Inc.
SMLR
$44.32
-$0.61-1.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.23M | 56.29M | 58.94M | 61.74M | 65.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.23M | 56.29M | 58.94M | 61.74M | 65.88M |
| Cost of Revenue | 4.45M | 4.76M | 4.57M | 4.52M | 4.49M |
| Gross Profit | 44.78M | 51.53M | 54.37M | 57.22M | 61.40M |
| SG&A Expenses | 27.20M | 25.81M | 26.88M | 27.90M | 29.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.62M | 35.36M | 36.41M | 37.38M | 39.69M |
| Operating Income | 12.61M | 20.93M | 22.52M | 24.36M | 26.19M |
| Income Before Tax | -34.78M | 47.89M | 18.12M | 18.74M | 25.27M |
| Income Tax Expenses | -4.91M | 6.99M | 2.21M | 2.92M | 3.58M |
| Earnings from Continuing Operations | -29.88 | 40.90 | 15.91 | 15.82 | 21.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.88M | 40.90M | 15.91M | 15.82M | 21.69M |
| EBIT | 12.61M | 20.93M | 22.52M | 24.36M | 26.19M |
| EBITDA | 12.77M | 21.14M | 22.75M | 24.64M | 26.45M |
| EPS Basic | -2.31 | 5.31 | 2.30 | 2.32 | 3.20 |
| Normalized Basic EPS | 0.32 | 3.90 | 1.90 | 2.04 | 2.68 |
| EPS Diluted | -2.61 | 4.92 | 2.04 | 2.03 | 2.78 |
| Normalized Diluted EPS | 0.10 | 3.60 | 1.69 | 1.79 | 2.32 |
| Average Basic Shares Outstanding | 31.62M | 28.92M | 27.69M | 27.36M | 27.12M |
| Average Diluted Shares Outstanding | 33.73M | 31.92M | 31.08M | 31.13M | 31.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |